| Approved? (Admin-only) |
|
|---|---|
| Opportunity Type | Private or Commercial |
| Funding Opportunity Posted By | MilliporeSigma |
| Funding Opportunity Title | North American Advance Biotech Grant Program |
| Link to Funding Opportunity | sigmaaldrich.com |
| Funding Opportunity Short Description | The Advance Biotech Grant Program is offered on a regular basis in different regions of the world. The program recognizes stand-out emerging biopharmaceutical and biotech start-ups and awards grant recipients with products, services, and consultation to advance production and help accelerate the path to commercialization. |
| Funding Opportunity Category | Health and Biomedical Technologies |
| Important Dates | |
| Full Applications Due | 04/30/2026 |
| Funding Details | |
| Award Ceiling | $238,400.00 |
| Funding Mechanism |
|
| Eligibility |
|
| Funding Opportunity Full Description | https://www.sigmaaldrich.com/US/en/applications/pharmaceutical-and-biopharmaceutical-manufacturing/biotech-resource-hub/startup-programs/advance-biotech-grant-rules The Advance Biotech Grant Program is offered on a regular basis in different regions of the world. The program recognizes stand-out emerging biopharmaceutical and biotech start-ups and awards grant recipients with products, services, and consultation to advance production and help accelerate the path to commercialization. Since 2014, more than 40 biotech startups have been recognized through this Program. We are honored to support their missions as they pursue therapeutic solutions for patients suffering from cancer, brain tumors, osteoarthritis, and cardiovascular disorders. To be considered for the grant, you must describe your therapeutic focus, clinical strategy, and explain how we can help you overcome challenges and address gaps in expertise to bring your innovation across the finish line. |
